Cerebrospinal fluid analyses in migraine patients and controls.
about
A 'complex' of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patientsEffects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model.Genotype-phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1.Cerebrospinal fluid biomarkers in primary headache disorders.Selected confirmed, probable, and exploratory migraine biomarkers.Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndromeExcitatory neurotransmitters in brain regions in interictal migraine patients.Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).Biomarkers associated with migraine and their potential role in migraine management.Is the migrainous brain normal outside of acute attacks? Lessons learned from psychophysical, neurochemical and functional neuroimaging studies.Metabolomic changes in CSF of migraine patients measured with 1H-NMR spectroscopy.Clinical studies of valproate for migraine prophylaxis.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on MigraineCerebrospinal fluid glutamate levels in chronic migraine.Metabolic assessment of a migraine model using relaxation-enhanced 1 H spectroscopy at ultrahigh field.Patterns of functional brain organization and migraine.Aminergic tone correlates of migraine and tension-type headache: a study using the tridimensional personality questionnaire.Increased Cerebrospinal Fluid Glycine: A Biochemical Marker for a Leukoencephalopathy With Vanishing White Matter
P2860
Q28834117-FDF3594B-13AA-4035-8D90-AEDA085556D2Q34124786-5F80C915-56CD-43D5-9092-1A1C43C7EA6AQ35658661-A3286689-8255-49E8-A3EC-00CC797C5EEFQ36546364-3A525F42-72C7-4AC2-B57B-2669B29B7610Q36546368-2175344C-1828-4CD3-9815-9EBFEB72CA43Q37140513-8E64D6A2-F069-42C4-A452-183A8169DC8EQ37271327-9FF5917A-F9D2-448C-A55A-38721A9BDE57Q37394217-AF3D7D3C-2032-4254-BF39-DCFEE260C728Q38121110-6D8664F9-605C-47A8-B378-B9E0371D44F7Q38140024-89AA1AAE-D909-4418-BDFB-1BB95829D608Q39297448-743A9C18-25B3-49C8-AB67-5D669F10EBA1Q41460262-A6BAF43B-E38A-4340-8159-A7EB67F764E7Q41572995-D49DE723-23BB-4742-ACC8-F3E193A4E072Q45021407-C5D941C7-4BEC-4DB1-A3B2-227EE043B27EQ45304283-AFC38E1F-6E01-4DF6-8369-53F2DA1AAE19Q52090356-61C07391-87C5-42A4-ADA9-8F10F8C0602CQ53329143-DB7E2951-3DAE-41CB-B3BC-011791E62D7EQ56618727-4CE3CEFF-03A2-4163-AE9C-4E072910C27A
P2860
Cerebrospinal fluid analyses in migraine patients and controls.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cerebrospinal fluid analyses in migraine patients and controls.
@ast
Cerebrospinal fluid analyses in migraine patients and controls.
@en
Cerebrospinal fluid analyses in migraine patients and controls.
@nl
type
label
Cerebrospinal fluid analyses in migraine patients and controls.
@ast
Cerebrospinal fluid analyses in migraine patients and controls.
@en
Cerebrospinal fluid analyses in migraine patients and controls.
@nl
prefLabel
Cerebrospinal fluid analyses in migraine patients and controls.
@ast
Cerebrospinal fluid analyses in migraine patients and controls.
@en
Cerebrospinal fluid analyses in migraine patients and controls.
@nl
P2093
P2860
P1433
P1476
Cerebrospinal fluid analyses in migraine patients and controls.
@en
P2093
P2860
P304
P356
10.1046/J.1468-2982.1995.1506489.X
P407
P577
1995-12-01T00:00:00Z